| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (880kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-514089
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.51408
Zusammenfassung
Antibody testing for determining the SARS-CoV-2 serostatus was rapidly introduced in early 2020 and since then has been gaining special emphasis regarding correlates of protection. With limited access to representative samples with known SARS-CoV-2 infection status during the initial period of test development and validation, spectrum bias has to be considered when moving from a "test ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik